Sumitomo Pharma Co., Ltd. (TYO:4506)

Sumitomo Pharma Revenue

In the fiscal year ending March 31, 2026, Sumitomo Pharma had annual revenue of 453.29B JPY with 13.66% growth. Sumitomo Pharma had revenue of 105.55B in the quarter ending March 31, 2026, a decrease of -0.10%.

• Revenue: 453.29B
• Revenue Growth: +13.66%
• P/S Ratio: 1.50
• Revenue / Employee: 118.29M
• Employees: 3,832
• Market Cap: 679.39B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	453.29B	54.46B	13.66%
Mar 31, 2025	398.83B	84.27B	26.79%
Mar 31, 2024	314.56B	-240.99B	-43.38%
Mar 31, 2023	555.54B	-4.49B	-0.80%
Mar 31, 2022	560.04B	44.08B	8.54%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 4, 2026

Data Sources Report a data error